Skip to main content
SEOUL PHARMA CO.,LTD logo

SEOUL PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 018680 ISIN · KR7018680009 KO Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2020-04-09 Regulatory Filings
Country KR South Korea
Listing KO 018680

About SEOUL PHARMA CO.,LTD

http://www.seoulpharmaceuticals.com/

Seoul Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. The company specializes in innovative drug delivery systems, with a core competency in Orally Disintegrating Film (ODF) technology. Its product portfolio includes a wide range of prescription and over-the-counter medications. Key therapeutic areas cover cardiovascular and respiratory systems, as well as anti-infective agents such as antibacterials, antifungals, and antivirals. The company also produces vitamins and antibiotics, aiming to improve health outcomes through its cutting-edge technological capabilities.

Recent filings

Filing Released Lang Actions
조회공시요구(현저한시황변동)
Regulatory Filings Classification · 95% confidence The document is a formal request from a regulatory body (exchange) to a company (Seoul Pharma) regarding significant market fluctuations (현저한 시황변동). This is a standard regulatory inquiry requiring a response by a specific deadline. Since it does not fit into specific categories like financial reports or shareholder meetings, it falls under the general regulatory filing category.
2020-04-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details the acquisition of shares and convertible bonds by '2018큐씨피13호 사모투자합자회사' in '(주)서울제약'. Since this is a mandatory disclosure of significant shareholding changes (crossing the 5% threshold), it falls under the category of Major Shareholding Notification.
2020-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a listed company. It details the acquisition of shares and convertible bonds by '2018큐씨피13호 사모투자합자회사' in '(주)서울제약'. Since this document reports a change in significant share ownership levels (crossing thresholds) by a major shareholder, it falls under the 'Major Shareholding Notification' category.
2020-04-01 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of new outside directors (Park Gyu-sik and Kim Han-soo) for Seoul Pharma. Since this document specifically announces changes to the board of directors, it falls under the 'Board/Management Information' category.
2020-03-30 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2019 (ending 2019-12-31), submitted to the Financial Services Commission and Korea Exchange on 2020-03-30. It contains comprehensive financial statements, management discussion and analysis, governance details, and auditor information. This structure corresponds to the standard Korean Annual Report filing (10-K equivalent). FY 2019
2020-03-30 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in shareholding percentage by Susung Asset Management in Seoul Pharma. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant ownership changes and thresholds.
2020-03-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.